A man in his 20s had completed chemotherapy for his early-stage Hodgkin lymphoma, a cancer of part of the immune system.
He wanted to resume his doctoral studies, but found it hard to focus and he was worried that he would have to drop his studies.
Please subscribe or log in to continue reading the full article. Learn more about ST PREMIUM.
We have been experiencing some problems with subscriber log-ins and apologise for the inconvenience caused. Until we resolve the issues, subscribers need not log in to access ST Digital articles. But a log-in is still required for our PDFs.